| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |